C004019 with a tau ligand (ID220149 [33]) and a VHL ligand (Figure 9) degraded tau proteins in the brain through subcutaneous administration in in vivo assay using wild-type, hTau-transgenic and 3xTg-AD mice with improvement of the synaptic and cognitive functions [34]. The gene discussed is MAPT; the disease is Alzheimer disease.